Eloxx Pharmaceuticals, Inc. (ELOX) — Net Income

Annual figures by fiscal year, from SEC filings.

1999: -$1.17M2000: -$3.35M2001: -$2.03M2002: -$3.02M2003: -$2.78M2004: -$3.73M2005: -$2.98M2006: -$3.31M2007: -$3.25M2008: -$4.60M2009: -$5.73M2010: -$13.38M2011: -$7.27M2012: -$5.07M2013: -$6.12M2014: -$9.23M2015: -$6.41M2016: -$9.85M2017: -$21.21M2018: -$47.19M2019: -$50.87M2020: -$34.58M2021: -$66.73M2022: -$36.06M2023: -$17.05M2024: -$3.14M2025: -$6.00M-$6.00M
1999Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$6.00M-90.7%
2024-$3.14M+81.6%
2023-$17.05M+52.7%
2022-$36.06M+46.0%
2021-$66.73M-93.0%
2020-$34.58M+32.0%
2019-$50.87M-7.8%
2018-$47.19M-122.4%
2017-$21.21M-115.4%
2016-$9.85M-53.7%
2015-$6.41M+30.6%
2014-$9.23M-50.7%
2013-$6.12M-20.9%
2012-$5.07M+30.3%
2011-$7.27M+45.7%
2010-$13.38M-133.7%
2009-$5.73M-24.5%
2008-$4.60M-41.5%
2007-$3.25M+1.9%
2006-$3.31M-11.3%
2005-$2.98M+20.1%
2004-$3.73M-34.2%
2003-$2.78M+8.1%
2002-$3.02M-48.6%
2001-$2.03M+39.2%
2000-$3.35M-186.3%
1999-$1.17M